160 related articles for article (PubMed ID: 37139621)
1. Berberine Affects the Proliferation, Migration, Invasion, Cell Cycle, and Apoptosis of Bladder Cancer Cells T24 and 5637 by Down-Regulating the HER2/PI3K/AKT Signaling Pathway.
Li Q; Qing L; Xu W; Yang Y; You C; Lao Y; Dong Z
Arch Esp Urol; 2023 Mar; 76(2):152-160. PubMed ID: 37139621
[TBL] [Abstract][Full Text] [Related]
2. Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathway.
Shen Z; Xue D; Wang K; Zhang F; Shi J; Jia B; Yang D; Zhang Q; Zhang S; Jiang H; Luo D; Li X; Zhong Q; Zhang J; Peng Z; Han Y; Sima C; He X; Hao L
BMC Urol; 2022 May; 22(1):79. PubMed ID: 35610639
[TBL] [Abstract][Full Text] [Related]
3. Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
Gao X; Liu J; Fan D; Li X; Fang Z; Yan K; Fan Y
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34935059
[TBL] [Abstract][Full Text] [Related]
4. Berberine Inhibited Growth and Migration of Human Colon Cancer Cell Lines by Increasing Phosphatase and Tensin and Inhibiting Aquaporins 1, 3 and 5 Expressions.
Tarawneh N; Hamadneh L; Abu-Irmaileh B; Shraideh Z; Bustanji Y; Abdalla S
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175233
[No Abstract] [Full Text] [Related]
5. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
Li Y; Shan Z; Liu C; Yang D; Wu J; Men C; Xu Y
Biochemistry (Mosc); 2017 Apr; 82(4):474-482. PubMed ID: 28371605
[TBL] [Abstract][Full Text] [Related]
6. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.
Wang Q; Wu H; Wu Q; Zhong S
Drug Dev Res; 2023 Aug; 84(5):907-921. PubMed ID: 37070571
[TBL] [Abstract][Full Text] [Related]
7. Cordycepin induces apoptosis in human bladder cancer T24 cells through ROS-dependent inhibition of the PI3K/Akt signaling pathway.
Kim SO; Cha HJ; Park C; Lee H; Hong SH; Jeong SJ; Park SH; Kim GY; Leem SH; Jin CY; Hwang EJ; Choi YH
Biosci Trends; 2019; 13(4):324-333. PubMed ID: 31527329
[TBL] [Abstract][Full Text] [Related]
8. Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
Jin D; Cao M; Mu X; Yang G; Xue W; Huang Y; Chen H
Cell Biochem Biophys; 2015 Apr; 71(3):1349-56. PubMed ID: 25388838
[TBL] [Abstract][Full Text] [Related]
9. Deoxyschizandrin Inhibits the Proliferation, Migration, and Invasion of Bladder Cancer Cells through ALOX5 Regulating PI3K-AKT Signaling Pathway.
Chi B; Sun Y; Zhao J; Guo Y
J Immunol Res; 2022; 2022():3079823. PubMed ID: 35664354
[TBL] [Abstract][Full Text] [Related]
10. Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer.
Li X; Liu H; Lv C; Du J; Lian F; Zhang S; Wang Z; Zeng Y
Biomed Res Int; 2022; 2022():9304552. PubMed ID: 35402614
[No Abstract] [Full Text] [Related]
11. Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo.
Zhang JJ; Cai LJ; Pang K; Dong Y; Zhang ZG; Li BB; Li R; Han CH
Clin Transl Oncol; 2021 Mar; 23(3):601-611. PubMed ID: 32691366
[TBL] [Abstract][Full Text] [Related]
12. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
Noguchi S; Yasui Y; Iwasaki J; Kumazaki M; Yamada N; Naito S; Akao Y
Cancer Lett; 2013 Jan; 328(2):353-61. PubMed ID: 23104321
[TBL] [Abstract][Full Text] [Related]
13. Flaccidoxide-13-Acetate Extracted from the Soft Coral Cladiella kashmani Reduces Human Bladder Cancer Cell Migration and Invasion through Reducing Activation of the FAK/PI3K/AKT/mTOR Signaling Pathway.
Neoh CA; Wu WT; Dai GF; Su JH; Liu CI; Su TR; Wu YJ
Molecules; 2017 Dec; 23(1):. PubMed ID: 29280977
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of migration and invasion by berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line.
Wang Y; Yuan J; Yang L; Wang P; Wang X; Wu Y; Chen K; Ma R; Zhong Y; Guo X; Gong Y; Gui M; Jin Y
Adv Clin Exp Med; 2018 Jul; 27(7):899-905. PubMed ID: 29790698
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway.
Kuo HP; Chuang TC; Yeh MH; Hsu SC; Way TD; Chen PY; Wang SS; Chang YH; Kao MC; Liu JY
J Agric Food Chem; 2011 Aug; 59(15):8216-24. PubMed ID: 21699261
[TBL] [Abstract][Full Text] [Related]
16. Andrographolide Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer Cells by Interfering with NF- κ B and PI3K/AKT Signaling In Vitro and In Vivo.
Xuan L; Hu JH; Bi R; Liu SQ; Wang CX
Chin J Integr Med; 2022 Apr; 28(4):349-356. PubMed ID: 35048242
[TBL] [Abstract][Full Text] [Related]
17. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway.
Liang W; Lai Y; Zhu M; Huang S; Feng W; Gu X
Med Sci Monit; 2016 Dec; 22():4911-4917. PubMed ID: 27966519
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
[TBL] [Abstract][Full Text] [Related]
19. Ropivacaine inhibits proliferation and invasion and promotes apoptosis and autophagy in bladder cancer cells via inhibiting PI3K/AKT pathway.
Qiao H; Zhang W; Liu P; Zhu R; Zhang J; Gao J; Li T; Zhang J
J Biochem Mol Toxicol; 2023 Jan; 37(1):e23233. PubMed ID: 36193553
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide Inhibits Proliferation and Induces Apoptosis via Suppressing Autophagy and PI3K/Akt Signaling Pathway in Human Bladder Cancer Cells.
Cheng L; Wang H; Wang Z; Huang H; Zhuo D; Lin J
Drug Des Devel Ther; 2020; 14():1897-1908. PubMed ID: 32546957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
